LIPO - Lipella Pharmaceuticals Inc Qarzning balans kapitallashuviga nisbati

Lipella Pharmaceuticals Inc (LIPO) grafik logotipi

Lipella Pharmaceuticals (LIPO) mahalliy dori vositalarini yetkazib berish tizimlarining diversifikatsiyalashgan portfelini ishlab chiqish orqali risklarni minimallashtiradi. Firma balansining kapitalizatsiyasidagi moliyaviy qarzlarning ulushi kredit yuklamasini aniq ko'rsatadi, bunda joriy holat 0.00 hisoblanadi. Rahbariyatning strategiyasi yallig'lanishni davolashning xavfsiz usullarini yaratishga qaratilgan bo'lib, bu urologiya sohasidagi brend kompetentsiyalariga ilmiy hamjamiyatning barqaror ishonchi bilan qo'llab-quvvatlanadi.

LIPO (Lipella Pharma) Qarzning balans qiymatiga nisbati tarixi 28.04.2023dan 19.07.2025gacha

Lipella Pharmaceuticals Inc (LIPO) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Lipella Pharmaceuticals|LIPO - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Lipella Pharma|LIPO - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Lipella Pharmaceuticals|LIPO - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati lipella.com|LIPO - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Lipella Pharmaceuticals|LIPO - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Lipella|LIPO - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Lipella Pharma
Kompaniyaning barcha koʻrsatkichlari tahlili:LIPO Lipella Pharmaceuticals
Lipella asosiy tovari

Lipella Pharmaceuticals kompaniyasining urologik tadqiqotlarning erta bosqichlariga tor ixtisoslashganligi tashqi kapitalga bo'lgan yuqori talabni keltirib chiqaradi. `dvsbcap_co` koeffitsiyenti balansning aktiv qiymati umumiy tuzilmasidagi qarz mablag'larining ulushini matematik tarzda ifodalaydi. Ushbu metrika moliyaviy leveraj darajasini va kompaniyaning kredit risklariga chidamliligini belgilaydi. Leverajni kamaytirish sinovlar muvaffaqiyatsiz tugagan taqdirda xavflarni minimallashtiradi, ammo kengayish sur'atlarini cheklaydi. Balans kapitaliga nisbatan joriy qarz darajasini tahlil qilish orqali investor uzoq muddatli o'sish va to'lov qobiliyati o'rtasidagi muvozanatni baholaydi.

Lipella Pharmaceuticals raqobatchilari

Balans kapitallashuviga qarzlar HLN (Haleon plc)|kenvue.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Verona Pharma (VRNA)|MENS: Qarzning sof aktivlarga nisbati|LGND (Ligand Pharma) - Qarzning balans kapitallashuviga nisbati|Amneal Corp (AMRX) - Qarzning balans qiymatiga nisbati|PRGO (Perrigo Company plc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar alvotech.com (ALVO)|Liquidia (LQDA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati GLPG (Galapagos N.V.)|ANIP: Qarzning balans kapitallashuviga nisbati|MNKD - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Amphastar Pharmaceuticals AMPH|PCRX - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar ARS Pharmaceuticals, Inc. SPRY|Theravance Biopharma Inc (TBPH) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar AQST (Aquestive Pharma)|Balans qiymatiga qarzlar SCPH|Tectonic Therapeutic, Inc. (TECX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati TNXP (tonixpharma.com)|Qarzning balans kapitallashuviga nisbati China SXT Pharmaceuticals, Inc. SXTC|Qarzning balans kapitallashuviga nisbati Eupraxia Pharmaceuticals, Inc. EPRX|Balans kapitallashuviga qarzlar BHST (BioHarvest)|EXOZ: Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati oramed.com (ORMP)|Entera Bio (ENTX) - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar HYFT (MindWalk Holdings Inc.)|Balans qiymatiga qarzlar ABVC|Qarzning balans kapitallashuviga nisbati Cumberland Pharma (CPIX)|Qarzning balans kapitallashuviga nisbati QNTM (Quantum BioPharma Corp)|Qarzning balans kapitallashuviga nisbati FibroGen, Inc. FGEN|Qarzning balans kapitallashuviga nisbati telomirpharma.com TELO|Rani Therapeutics Inc - Balans kapitallashuviga qarzlar|Synergy CHC Corp (SNYR) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati rallybio.com RLYB|LEXX (Lexaria Bioscience Corp.) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Pulmatrix, Inc. PULM|Qarzlarning balans kapitallashuviga nisbati Pheton|Aptorum Group Limited (APM) - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Lyra Therapeutics Inc. (LYRA)|Balans kapitallashuviga qarzlar IBO (Impact BioMedical Inc)|TNF Pharmaceuticals Inc. - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati cbdMD Corp (YCBD)|PRFX: Qarzning sof aktivlarga nisbati|CYTO (altamiratherapeutics.com) - Qarzning balans kapitallashuviga nisbati|OptiNose Inc (OPTN) - Qarzning balans qiymatiga nisbati|PIRS (Pieris) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Procaps Group Corp|Balans kapitallashuviga qarzlar PTPI (Petros Pharmaceuticals)|Qarzning balans qiymatiga nisbati qlsyy.net (QLI)|SLRN: Balans kapitallashuviga qarzlar|TFFP - Balans qiymatiga qarzlar